IL-17A promoted cervical cancer cells migration and invasion.

Abstract

<p>(<b>A, B</b>) Compared with control group cells, IL-17A treated cervical cancer cells (HeLa, C33 A, and Caski) showed higher motility in a wound-healing assay. (<b>C</b>) By cell invasive assay, the effect of IL-17A on cell invasion was detected (magnification 100×). (<b>D</b>) Total invasive cell number in each chamber was summarized. Values are represented as means ± SD of three independent experiments performed in triplicate. * <i>p</i><0.05 and ** <i>p</i><0.01 compared with control group respectively.</p